298 related articles for article (PubMed ID: 10527268)
21. Modern management of splenomegaly in patients with myelofibrosis.
Tremblay D; Schwartz M; Bakst R; Patel R; Schiano T; Kremyanskaya M; Hoffman R; Mascarenhas J
Ann Hematol; 2020 Jul; 99(7):1441-1451. PubMed ID: 32417942
[TBL] [Abstract][Full Text] [Related]
22. Erythroleukemia following erythropoietin therapy, extramedullary hematopoiesis, and splenectomy in a patient with myelofibrosis and myeloid metaplasia.
Coleman TA; Hamill RL; Ford SM
Am J Hematol; 2001 Jul; 67(3):214-5. PubMed ID: 11391725
[No Abstract] [Full Text] [Related]
23. Splenectomy for massive splenomegaly.
Coon WW
Surg Gynecol Obstet; 1989 Sep; 169(3):235-7. PubMed ID: 2772794
[TBL] [Abstract][Full Text] [Related]
24. Splenic irradiation provides transient palliation for symptomatic splenomegaly associated with primary myelofibrosis: a report on 14 patients.
Kitanaka A; Takenaka K; Shide K; Miyamoto T; Kondo T; Ozawa K; Kurokawa M; Akashi K; Shimoda K
Int J Hematol; 2016 Apr; 103(4):423-8. PubMed ID: 26791378
[TBL] [Abstract][Full Text] [Related]
25. The spleen in myeloproliferative disorders.
Goldman JM; Nolasco I
Clin Haematol; 1983 Jun; 12(2):505-16. PubMed ID: 6352114
[No Abstract] [Full Text] [Related]
26. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Barosi G; Bacigalupo A
Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
[TBL] [Abstract][Full Text] [Related]
27. Surgical and radiotherapeutic approaches for myelofibrosis with myeloid metaplasia.
Mesa RA; Tefferi A
Semin Oncol; 2005 Aug; 32(4):403-13. PubMed ID: 16202686
[TBL] [Abstract][Full Text] [Related]
28. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature.
Chen SW; Hwang WS; Tsao CJ; Liu HS; Huang GC
J Clin Pharm Ther; 2005 Dec; 30(6):623-5. PubMed ID: 16336296
[TBL] [Abstract][Full Text] [Related]
29. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
Brenner B; Nagler A; Tatarsky I; Hashmonai M
Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
[TBL] [Abstract][Full Text] [Related]
30. Long-term analysis of the palliative benefit of 2-chlorodeoxyadenosine for myelofibrosis with myeloid metaplasia.
Faoro LN; Tefferi A; Mesa RA
Eur J Haematol; 2005 Feb; 74(2):117-20. PubMed ID: 15654901
[TBL] [Abstract][Full Text] [Related]
31. [Myeloid metaplasia in the course of splenic miliary tuberculosis and results obtained by splenectomy].
Aksoy M; Sagun N; Erdem S; Başerer G
Turk Tip Cemiy Mecm; 1967 Feb; 33(2):92-7. PubMed ID: 6066641
[No Abstract] [Full Text] [Related]
32. Preoperative splenic artery occlusion as an adjunct for high risk splenectomy.
Fujitani RM; Johs SM; Cobb SR; Mehringer CM; White RA; Klein SR
Am Surg; 1988 Oct; 54(10):602-8. PubMed ID: 3178046
[TBL] [Abstract][Full Text] [Related]
33. Myelofibrosis with myeloid metaplasia: disease overview and non-transplant treatment options.
Mesa RA; Barosi G; Cervantes F; Reilly JT; Tefferi A
Best Pract Res Clin Haematol; 2006; 19(3):495-517. PubMed ID: 16781486
[TBL] [Abstract][Full Text] [Related]
34. Palliative irradiation of the spleen.
McFarland JT; Kuzma C; Millard FE; Johnstone PA
Am J Clin Oncol; 2003 Apr; 26(2):178-83. PubMed ID: 12714892
[TBL] [Abstract][Full Text] [Related]
35. Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders.
Sager O; Beyzadeoglu M; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Akin M; Gundem E; Dirican B
Tumori; 2015; 101(1):84-90. PubMed ID: 25702680
[TBL] [Abstract][Full Text] [Related]
36. [Myelofibrosis with myeloid metaplasia: diagnosis and treatment].
Dupriez B; Demory JL
Rev Prat; 2005 Oct; 55(15):1680-5. PubMed ID: 16334205
[TBL] [Abstract][Full Text] [Related]
37. Agnogenic myeloid metaplasia; its current managment.
Silverstein MN
Minn Med; 1970 Mar; 53(3):257-9. PubMed ID: 5415744
[No Abstract] [Full Text] [Related]
38. Splenic irradiation for myelofibrosis prior to hematopoietic cell transplantation: A global collaborative analysis.
Gagelmann N; Hobbs GS; Campodonico E; Helbig G; Novak P; Schroeder T; Schneider A; Rautenberg C; Reinhardt HC; Bosques L; Heuser M; Panagiota V; Thol F; Gurnari C; Maciejewski JP; Ciceri F; Rathje K; Robin M; Pagliuca S; Rubio MT; Rocha V; Funke V; Hamerschlak N; Salit R; Scott BL; Duarte F; Mitrus I; Czerw T; Greco R; Kröger N
Am J Hematol; 2024 May; 99(5):844-853. PubMed ID: 38357714
[TBL] [Abstract][Full Text] [Related]
39. Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses - follow-up of three patients.
Fruehauf S; Buss EC; Topaly J; Kreipe HH; Ho AD
Haematologica; 2005 Feb; 90(2):ECR08. PubMed ID: 15713582
[TBL] [Abstract][Full Text] [Related]
40. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
